Key result
Microvascular disease is linked to ~270% higher amputation risk, rising synergistically when combined with PAD.
Why the study?
The mechanism of adverse limb events associated with peripheral artery disease remains incompletely understood, particularly the role of microvascular disease in amputation risk.
Does the presence of microvascular disease increase the risk of amputation in patients with or without peripheral artery disease?
Cohort (n=125,674)
Does the presence of microvascular disease increase the risk of amputation in patients with or without peripheral artery disease?
Microvascular disease independently increases the risk of amputation and acts synergistically with peripheral artery disease to further elevate this risk.
Answers are grounded in this paper and cite their sources.
May warrant closer amputation surveillance in veterans with combined disease; leaves open whether microvascular therapies alter outcomes.
BACKGROUND: The mechanism of adverse limb events associated with peripheral artery disease remains incompletely understood. We investigated whether microvascular disease is associated with amputation in a large cohort of veterans to determine whether microvascular disease diagnosed in any location increases the risk of amputation alone and in concert with peripheral artery disease. METHODS: Participants in the Veterans Aging Cohort Study were recruited from April 1, 2003 through December 31, 2014. We excluded participants with known prior lower limb amputation. Using time-updated Cox proportional hazards regression, we analyzed the effect of prevalent microvascular disease (retinopathy, neuropathy, and nephropathy) and peripheral artery disease status on the risk of incident amputation events after adjusting for demographics and cardiovascular risk factors. RESULTS: Among 125 674 veterans without evidence of prior amputation at baseline, the rate of incident amputation over a median of 9.3 years of follow-up was 1.16 per 1000 person-years, yielding a total of 1185 amputations. In time-updated multivariable-adjusted analyses, compared with those without peripheral artery disease or microvascular disease, microvascular disease alone was associated with a 3.7-fold (95% CI, 3.0-4.6) increased risk of amputation; peripheral artery disease alone conferred a 13.9-fold (95% CI, 11.3-17.1) elevated risk of amputation; and the combination of peripheral artery disease and microvascular disease was associated with a 22.7-fold (95% CI, 18.3-28.1) increased risk of amputation. CONCLUSIONS: Independent of traditional risk factors, the presence of microvascular disease increases the risk of amputation alone and synergistically increases risk in patients with peripheral artery disease. Further research is needed to understand the mechanisms by which this occurs.
No takes yet. Share an insight, caveat, or question.
Beckman et al. (2019) conducted a cohort in Peripheral artery disease and microvascular disease (n=125,674). Microvascular disease vs. No peripheral artery disease or microvascular disease was evaluated on Incident amputation (HR 3.7, 95% CI 3.0-4.6). Microvascular disease alone increased amputation risk 3.7-fold compared to no disease, and synergistically increased risk 22.7-fold when combined with peripheral artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: